These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 33146689)

  • 1. Association of Circulating Monocyte Chemoattractant Protein-1 Levels With Cardiovascular Mortality: A Meta-analysis of Population-Based Studies.
    Georgakis MK; de Lemos JA; Ayers C; Wang B; Björkbacka H; Pana TA; Thorand B; Sun C; Fani L; Malik R; Dupuis J; Engström G; Orho-Melander M; Melander O; Boekholdt SM; Zierer A; Elhadad MA; Koenig W; Herder C; Hoogeveen RC; Kavousi M; Ballantyne CM; Peters A; Myint PK; Nilsson J; Benjamin EJ; Dichgans M
    JAMA Cardiol; 2021 May; 6(5):587-592. PubMed ID: 33146689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Monocyte Chemoattractant Protein-1 and Risk of Stroke: Meta-Analysis of Population-Based Studies Involving 17 180 Individuals.
    Georgakis MK; Malik R; Björkbacka H; Pana TA; Demissie S; Ayers C; Elhadad MA; Fornage M; Beiser AS; Benjamin EJ; Boekholdt SM; Engström G; Herder C; Hoogeveen RC; Koenig W; Melander O; Orho-Melander M; Schiopu A; Söderholm M; Wareham N; Ballantyne CM; Peters A; Seshadri S; Myint PK; Nilsson J; de Lemos JA; Dichgans M
    Circ Res; 2019 Sep; 125(8):773-782. PubMed ID: 31476962
    [No Abstract]   [Full Text] [Related]  

  • 3. Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM
    Brunekreef B; Strak M; Chen J; Andersen ZJ; Atkinson R; Bauwelinck M; Bellander T; Boutron MC; Brandt J; Carey I; Cesaroni G; Forastiere F; Fecht D; Gulliver J; Hertel O; Hoffmann B; de Hoogh K; Houthuijs D; Hvidtfeldt U; Janssen N; Jorgensen J; Katsouyanni K; Ketzel M; Klompmaker J; Hjertager Krog N; Liu S; Ljungman P; Mehta A; Nagel G; Oftedal B; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rodopoulou S; Samoli E; Schwarze P; Sigsgaard T; Stafoggia M; Vienneau D; Weinmayr G; Wolf K; Hoek G
    Res Rep Health Eff Inst; 2021 Sep; 2021(208):1-127. PubMed ID: 36106702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis.
    Deo R; Khera A; McGuire DK; Murphy SA; Meo Neto Jde P; Morrow DA; de Lemos JA
    J Am Coll Cardiol; 2004 Nov; 44(9):1812-8. PubMed ID: 15519012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals.
    Aung T; Halsey J; Kromhout D; Gerstein HC; Marchioli R; Tavazzi L; Geleijnse JM; Rauch B; Ness A; Galan P; Chew EY; Bosch J; Collins R; Lewington S; Armitage J; Clarke R;
    JAMA Cardiol; 2018 Mar; 3(3):225-234. PubMed ID: 29387889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monocyte chemoattractant protein-1 and recurrent cardiovascular events in patients with stable coronary heart disease.
    Haim M; Tanne D; Boyko V; Reshef T; Goldbourt U; Battler A; Mekori YA; Behar S
    Clin Cardiol; 2005 Jan; 28(1):31-5. PubMed ID: 15704530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes.
    de Lemos JA; Morrow DA; Sabatine MS; Murphy SA; Gibson CM; Antman EM; McCabe CH; Cannon CP; Braunwald E
    Circulation; 2003 Feb; 107(5):690-5. PubMed ID: 12578870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.
    ; Danesh J; Lewington S; Thompson SG; Lowe GD; Collins R; Kostis JB; Wilson AC; Folsom AR; Wu K; Benderly M; Goldbourt U; Willeit J; Kiechl S; Yarnell JW; Sweetnam PM; Elwood PC; Cushman M; Psaty BM; Tracy RP; Tybjaerg-Hansen A; Haverkate F; de Maat MP; Fowkes FG; Lee AJ; Smith FB; Salomaa V; Harald K; Rasi R; Vahtera E; Jousilahti P; Pekkanen J; D'Agostino R; Kannel WB; Wilson PW; Tofler G; Arocha-Piñango CL; Rodriguez-Larralde A; Nagy E; Mijares M; Espinosa R; Rodriquez-Roa E; Ryder E; Diez-Ewald MP; Campos G; Fernandez V; Torres E; Marchioli R; Valagussa F; Rosengren A; Wilhelmsen L; Lappas G; Eriksson H; Cremer P; Nagel D; Curb JD; Rodriguez B; Yano K; Salonen JT; Nyyssönen K; Tuomainen TP; Hedblad B; Lind P; Loewel H; Koenig W; Meade TW; Cooper JA; De Stavola B; Knottenbelt C; Miller GJ; Cooper JA; Bauer KA; Rosenberg RD; Sato S; Kitamura A; Naito Y; Palosuo T; Ducimetiere P; Amouyel P; Arveiler D; Evans AE; Ferrieres J; Juhan-Vague I; Bingham A; Schulte H; Assmann G; Cantin B; Lamarche B; Després JP; Dagenais GR; Tunstall-Pedoe H; Woodward M; Ben-Shlomo Y; Davey Smith G; Palmieri V; Yeh JL; Rudnicka A; Ridker P; Rodeghiero F; Tosetto A; Shepherd J; Ford I; Robertson M; Brunner E; Shipley M; Feskens EJ; Kromhout D; Dickinson A; Ireland B; Juzwishin K; Kaptoge S; Lewington S; Memon A; Sarwar N; Walker M; Wheeler J; White I; Wood A
    JAMA; 2005 Oct; 294(14):1799-809. PubMed ID: 16219884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetically Determined Levels of Circulating Cytokines and Risk of Stroke.
    Georgakis MK; Gill D; Rannikmäe K; Traylor M; Anderson CD; Lee JM; Kamatani Y; Hopewell JC; Worrall BB; Bernhagen J; Sudlow CLM; Malik R; Dichgans M
    Circulation; 2019 Jan; 139(2):256-268. PubMed ID: 30586705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of Serum Nonesterified Fatty Acids With Coronary Heart Disease Mortality and Nonfatal Myocardial Infarction: The CHS (Cardiovascular Health Study) Cohort.
    Huang NK; Bůžková P; Matthan NR; Djoussé L; Hirsch CH; Kizer JR; Longstreth WT; Mukamal KJ; Lichtenstein AH
    J Am Heart Assoc; 2021 Mar; 10(6):e019135. PubMed ID: 33682438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Mitochondrial DNA Copy Number With Cardiovascular Disease.
    Ashar FN; Zhang Y; Longchamps RJ; Lane J; Moes A; Grove ML; Mychaleckyj JC; Taylor KD; Coresh J; Rotter JI; Boerwinkle E; Pankratz N; Guallar E; Arking DE
    JAMA Cardiol; 2017 Nov; 2(11):1247-1255. PubMed ID: 29049454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smoking cessation for secondary prevention of cardiovascular disease.
    Wu AD; Lindson N; Hartmann-Boyce J; Wahedi A; Hajizadeh A; Theodoulou A; Thomas ET; Lee C; Aveyard P
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD014936. PubMed ID: 35938889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
    Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Monocyte Chemoattractant Protein-1 with Death and Atherosclerotic Events in Chronic Kidney Disease.
    Gregg LP; Tio MC; Li X; Adams-Huet B; de Lemos JA; Hedayati SS
    Am J Nephrol; 2018; 47(6):395-405. PubMed ID: 29874658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Fibroblast Growth Factor 23 With Risk of Incident Coronary Heart Disease in Community-Living Adults.
    Panwar B; Judd SE; Wadley VG; Jenny NS; Howard VJ; Safford MM; Gutiérrez OM
    JAMA Cardiol; 2018 Apr; 3(4):318-325. PubMed ID: 29516098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study.
    McDermott DH; Yang Q; Kathiresan S; Cupples LA; Massaro JM; Keaney JF; Larson MG; Vasan RS; Hirschhorn JN; O'Donnell CJ; Murphy PM; Benjamin EJ
    Circulation; 2005 Aug; 112(8):1113-20. PubMed ID: 16116069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum ferritin and death from all causes and cardiovascular disease: the NHANES II Mortality Study. National Health and Nutrition Examination Study.
    Sempos CT; Looker AC; Gillum RE; McGee DL; Vuong CV; Johnson CL
    Ann Epidemiol; 2000 Oct; 10(7):441-8. PubMed ID: 11023623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma MCP-1 level and risk for peripheral arterial disease and incident coronary heart disease: Atherosclerosis Risk in Communities study.
    Hoogeveen RC; Morrison A; Boerwinkle E; Miles JS; Rhodes CE; Sharrett AR; Ballantyne CM
    Atherosclerosis; 2005 Dec; 183(2):301-7. PubMed ID: 16285993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Sickle Cell Trait With Incidence of Coronary Heart Disease Among African American Individuals.
    Hyacinth HI; Franceschini N; Seals SR; Irvin MR; Chaudhary N; Naik RP; Alonso A; Carty CL; Burke GL; Zakai NA; Winkler CA; David VA; Kopp JB; Judd SE; Adams RJ; Gee BE; Longstreth WT; Egede L; Lackland DT; Greenberg CS; Taylor H; Manson JE; Key NS; Derebail VK; Kshirsagar AV; Folsom AR; Konety SH; Howard V; Allison M; Wilson JG; Correa A; Zhi D; Arnett DK; Howard G; Reiner AP; Cushman M; Safford MM
    JAMA Netw Open; 2021 Jan; 4(1):e2030435. PubMed ID: 33399855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous Dose-Response Association Between Sedentary Time and Risk for Cardiovascular Disease: A Meta-analysis.
    Pandey A; Salahuddin U; Garg S; Ayers C; Kulinski J; Anand V; Mayo H; Kumbhani DJ; de Lemos J; Berry JD
    JAMA Cardiol; 2016 Aug; 1(5):575-83. PubMed ID: 27434872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.